三种抗菌药物治疗呼吸道感染成本-效果比较  

Cost-Effectiveness comparision Amony Ceftriazone, Penicillin, and Ciprofluxacin in Treatment of Lower Resipiratory Tract Infection

作　　者：李惠民[1] 张能忠[1] 吴丽敏[1] 

机构地区：[1]广东省深圳市宝安区人民医院,518101

出　　处：《医药导报》2001年第6期364-365,共2页Herald of Medicine

摘　　要：目的 :比较头孢曲松、青霉素和环丙沙星治疗下呼吸道感染的疗效及经济成本。方法 :运用药物经济学原理对头孢曲松、青霉素和环丙沙星治疗下呼吸道感染成本 效果进行比较分析。结果 :三种药物在治疗下呼吸道感染时 ,疗效相同 ,青霉素的成本最低。结论 :青霉素是治疗下呼吸道感染的首选药物。Objective:To compare amony ceftriazone, penicillin, and ciprofluxacin in the treatment of lower respiratory tract infection. Methods:Cost-effectiveness was comparitively analysed by using the principle of pharmacoeconomics with ceftriazone, penicillin, and ciprofluxacin in the treatment of lower respiratory tract infection. Results:Three drugs in the treatment of lower respiratory trace infection, while cost of penicillin was the lowest. Conclusion:Penicillin is a first selective drugs for lower respiratory tract infection.

关 键 词：头孢曲松 青霉素 环丙沙星 成本-效果分析 呼吸道感染 治疗 

分 类 号：R978.1[医药卫生—药品] R56[医药卫生—药学]